Proximity induced degradation has only just begun!
The @US_FDA approved the protein degrader vepdegestrant for adults with previously treated ER-positive, HER2-negative advanced or metastatic breast cancer with ESR1 mutations: buff.ly/B0gPzIW
Udai Banerji
FDA approves vepdegestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer